tirzepatide vs semaglutide compounded Troubling Findings in Study of GLP-1 Compounders Tirzepatide vs Semaglutide: Weight Loss

The results so far are highly encouraging: patients can lose 1520% of body weight in a year with just 12 injections

Industry analysts project retatrutide will likely fall in a similar range to tirzepatide, possibly with a premium given its enhanced efficacy profile

Educational panel available for free via the Life Time App 6:00-7:30 p.m

If the goal is a needle-free option with daily habit-building and a gentler entry point, an ODT may be worth discussing

In the search for the best liposomal glutathione, I have come to realise that consistency is the most important thing

With approximately 25 million projected GLP-1 users by 2030 up from roughly 11 million in 2025 and the behavioral evidence showing consistent, durable changes in eating patterns, the brands that adapt their packaging, portions, and nutritional profiles now will build a competitive advantage that compounds over time